HLD-0915 is a RIPTAC therapeutic designed to selectively target prostate cancer tumor cells by binding together the androgen receptor with an essential effector protein.

Future prospective studies will be necessary to assess potential causation of sucralose in driving immunotherapy resistance as well as to determine how other demographic factors, including location ...

The sodium chloride 0.9% injection shortage is resolved, and it will be removed from the FDA Drug Shortage Database; facilities are advised to use FDA-approved products when available. The FDA is ...

Independent factors tied to adenoma detection rate include AI exposure, male versus female patient sex, patient age 60 years or older vs younger than 60.

DASH4D -- diet is similar to the original DASH diet but lower in carbohydrates and higher in unsaturated fats.

In emergency rooms and operating theaters, scrubs were consistently favored, but overall, the white coat still symbolizes professionalism.

HealthDay News — Most individuals living in underserved communities believe that dermatologic side effects (DSEs) from anticancer therapies (ACTs) occur at high rates, according to a study published ...

HealthDay News — Metformin use is associated with lower risks for dementia and all-cause mortality across body mass index (BMI) groups in patients with overweight or obesity, according to a study ...

Palivizumab was the only approved therapy to prevent severe RSV disease in infants and young children until the approval of nirsevimab in 2023.

"If you see increased wastewater viral activity levels, it might indicate that there is a higher risk of infection." ...

Patients with postural orthostatic tachycardia syndrome treated with ivabradine have better heart-rate control when standing.

CELZ-201-DDT is a regenerative stem cell-based therapy being developed as a potential treatment for chronic low back pain associated with degenerative disc disease.